pharmacovigilance (2)

According to the latest market research study published by P&S Intelligence, the global pharmacovigilance market is poised for significant growth, with projections indicating a rise from USD 8,340.1 million in 2024 to USD 18,026.7 million by 2030, reflecting a CAGR of 13.9%. This expansion is primarily driven by the increasing incidence of adverse drug reactions (ADRs) and a heightened focus on drug safety and efficacy. Additionally, the integration of artificial intelligence (AI) and machine le

Read more…

 

For more information, contact: ExL Events                                 FOR IMMEDIATE RELEASE

Phone: 866-207-6528

Email: registration@exlevents.com

 

Ply Emerging Technologies and Effective SOPs to Enhance Regulatory Compliance and the Quality of Your Safety System”

ExL Events is hosting the 4th Adverse Events Reporting and Safety Strategies Summit on December 4–5, 2017 at the Sonesta Philadelphia Rittenhouse Square in Philadelphia, PA.

This summit will offer an in-depth analysis of real-world dat

Read more…

    About Us

    The GlobalRisk Community is a thriving community of risk managers and associated service providers. Our purpose is to foster business, networking and educational explorations among members. Our goal is to be the worlds premier Risk forum and contribute to better understanding of the complex world of risk.

    Business Partners

    For companies wanting to create a greater visibility for their products and services among their prospects in the Risk market: Send your business partnership request by filling in the form here!

lead